Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20034276HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20034277HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20034280HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20047208HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20034278HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20034282HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20034283HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20047211HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20047209HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20034281HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TCGA Plot Options
Drug Information
GeneHTR1D
DrugBank IDDB00315
Drug NameZolmitriptan
Target IDBE0000659
UniProt IDP28221
Regulation Typeagonist
PubMed IDs11513839; 9399012; 29352859
CitationsJohnson DE, Rollema H, Schmidt AW, McHarg AD: Serotonergic effects and extracellular brain levels of eletriptan, zolmitriptan and sumatriptan in rat brain. Eur J Pharmacol. 2001 Aug 17;425(3):203-10.@@Martin GR: Pre-clinical pharmacology of zolmitriptan (Zomig; formerly 311C90), a centrally and peripherally acting 5HT1B/1D agonist for migraine. Cephalalgia. 1997 Oct;17 Suppl 18:4-14.@@Rubio-Beltran E, Labastida-Ramirez A, Villalon CM, MaassenVanDenBrink A: Is selective 5-HT1F receptor agonism an entity apart from that of the triptans in antimigraine therapy? Pharmacol Ther. 2018 Jun;186:88-97. doi: 10.1016/j.pharmthera.2018.01.005. Epub 2018 Jan 17.
GroupsApproved; Investigational
Direct ClassificationTryptamines and derivatives
SMILESCN(C)CCC1=CNC2=CC=C(C[C@H]3COC(=O)N3)C=C12
Pathways
PharmGKBPA451975
ChEMBLCHEMBL1185